WHO prequalifies first biosimilar medicine to increase access to cancer treatment
The World Health Organization (WHO) has prequalified its first biosimilar medicine, trastuzumab in a move to enable women with breast cancer all over the world get affordable and accessible treatment.
Follow Us on Google News